NABEL ELIZABETH G 4

What Happened

• Elizabeth G. Nabel, a director of Moderna, had 16,233 restricted stock units (RSUs) vest and convert into 16,233 shares of common stock on April 30, 2026 (transaction code M = conversion of derivative). The filing also shows a simultaneous disposal of 16,233 shares at $0.00. No cash purchase price is reported for the conversion.

Key Details

• Transaction date: April 30, 2026 (reported on Form 4 filed May 4, 2026; Period of Report: 2026-04-30).
• Acquired: 16,233 shares via conversion of RSUs (price: N/A for conversion).
• Disposed: 16,233 shares at $0.00 (reported as derivative disposal).
• Shares owned after the transaction: not specified in this filing.
• Footnotes: F1 — RSUs convert one-for-one into common stock; F2 — these RSUs vested in full on April 30, 2026.
• Filing timing: Form 4 filed May 4, 2026 (four days after the transaction date); the filing itself does not state whether any late-filing designation applies.

Context

• This appears to be a routine vesting/conversion of RSUs rather than an open-market buy or sale. A disposal reported at $0.00 in conjunction with RSU conversion often (but not always) reflects net settlement or shares withheld to cover taxes; the Form 4 does not specify the reason for the disposition. Such vesting events are common compensation-related transactions and are not by themselves a directional endorsement of the stock.